検索に戻る
案件記録

IDENTIFYING CANCER THERAPIES

発明審査中
1閲覧数
19請求項 · 1 独立
§ Ⅰ

案件概要

発明者

Rob Kimmerling; Selim Olcum; Clifford Reid; Mark Stevens

IPC分類

G16B 20/G1N 33/50G16H 10/40G16H 50/20G16H 50/30

CPC分類

G16B20/G1N33/5011G1N33/5067G16H10/40G16H50/20G1N2800/52G1N2800/60G16H50/30

In silico tools are used to determine possibly effective therapies for treating a patient's cancer based on patient, drug, and cancer information. Functional assays can be performed on living cancer cells from the patient to evaluate the possibly effective therapies along with subsequent genomic or other more destructive assays to provide additional information from a single sample. Drug, patient, cancer, and outcome information can be recorded and updated iteratively and analyzed using machine learning to identify correlations between various patient, cancer, and drug characteristics and expected outcomes and drug efficacies.

原文(中国語)

In silico tools are used to determine possibly effective therapies for treating a patient's cancer based on patient, drug, and cancer information. Functional assays can be performed on living cancer cells from the patient to evaluate the possibly effective therapies along with subsequent genomic or other more destructive assays to provide additional information from a single sample. Drug, patient, cancer, and outcome information can be recorded and updated iteratively and analyzed using machine learning to identify correlations between various patient, cancer, and drug characteristics and expected outcomes and drug efficacies.

外部リソース